Population |
1,141, 785 |
Fixed |
[50] |
Prevalence of epilepsy |
7.7 per 1,000 |
Fixed |
[18] |
Proportion of epilepsy due to NCC |
0.07 |
Uniform (0.002–0.158) |
[51–53] |
Case fatality ratio for NCC (%) |
0.11 |
Beta (0.02–0.22) |
[18] |
Age of onset for age group 0–4 years |
2.0 |
Fixed |
[54] |
Age of onset for age group 5–14 years |
9.9 |
Fixed |
[54] |
Age of onset for age group 15–44 years |
26.9 |
Fixed |
[54] |
Age of onset for age group 45–59 years |
51.9 |
Fixed |
[54] |
Age of onset for age group over 60 years |
73.6 |
Fixed |
[54] |
Average duration for age group 0–4 years |
1.4 |
Fixed |
[55] |
Average duration for age group 5–14 years |
2.0 |
Fixed |
[55] |
Average duration for age group 15–44 years |
3.6 |
Fixed |
[55] |
Average duration for age group 45–59 years |
2.8 |
Fixed |
[55] |
Average duration for age group over 60 years |
1.6 |
Fixed |
[55] |
Disability weights for epilepsy treated |
0.076 |
Uniform (0.047–0.106) |
[56] |
Disability weights for epilepsy untreated |
0.424 |
Uniform (0.279–0.572) |
[56] |